SCHEMBL3913346

SCHEMBL3913346

Cc1oc(-c2ccc(F)cc2)cc1C(=O)N(Cc1ccccc1)c1cccc(CO)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 3/20 0.51
▸ PDK1 Q15118 5/20 0.41
▸ LTB4R2 Q9NPC1 4/20 0.41
▸ NPC1 O15118 2/20 0.40
▸ KMT2A Q03164 3/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ JAK2 O60674 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ PAX8 Q06710 1/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3901597 0.88 RAB9A (0.37) RAB9APDK1LTB4R2NPC1KMT2A
SCHEMBL13802104 0.87 RAB9A (0.48) RAB9APDK1NPC1KMT2AALDH1A1
SCHEMBL13791108 0.87 RAB9A (0.46) RAB9APDK1LTB4R2NPC1KMT2A
SCHEMBL3905610 0.85 ALDH1A1 (0.39) RAB9ANPC1KMT2AALDH1A1MEN1
SCHEMBL3906995 0.85 RAB9A (0.46) RAB9APDK1LTB4R2NPC1KMT2A
SCHEMBL3913375 0.85 RAB9A (0.40) RAB9ALTB4R2NPC1KMT2AALDH1A1
SCHEMBL3903353 0.76 MEN1 (0.57) RAB9APDK1NPC1KMT2AALDH1A1
SCHEMBL13791085 0.74 CYP1A2 (0.39) RAB9ANPC1KMT2AALDH1A1MEN1
SCHEMBL13802095 0.73 ALDH1A1 (0.38) RAB9ANPC1KMT2AALDH1A1MEN1
SCHEMBL3905527 0.72 MAPT (0.41) RAB9ANPC1KMT2AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7553867-B2 Furan or thiophene derivative and medicinal use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-30 — — US disclosed
US-7553867-B2 Furan or thiophene derivative and medicinal use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-30 — — US disclosed
US-7553867-B2 Furan or thiophene derivative and medicinal use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-30 — — US disclosed
US-20060100261-A1 Furan or thiopene derivative and medicinal use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED INTELLECTUAL PROPERTY DEPARTMENT (JP) 2006-05-11 — — US disclosed
EP-1535915-A1 FURAN OR THIOPHENE DERIVATIVE AND MEDICINAL USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2005-06-01 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100261-A1 Furan or thiopene derivative and medicinal use thereof TXN2, CYP11B2, CYP11B1 RAB9A 4758/4885PDK1 1681/4885LTB4R2 40/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback